Paragraph 43 List of countries for the purposes of the definition of “homoeopathic medicinal product” on IP completion dayF1

For the purposes of the definition of “homoeopathic medicinal product” in regulation 8 (general interpretation: accepted Pharmacopoeias for homoeopathic manufacturing procedures), during the transitional period, the licensing authority must publish a list of countries that includes each EEA State in it.

The licensing authority must not, before the end of the transitional period, remove an EEA State from the list described in sub-paragraph (1).

In this paragraph, “the transitional period” is the period of two years beginning with IP completion day.